Paranasal Sinus Cancer
📧 Sign up to get email alerts when something new happens for Paranasal Sinus Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
A clinical trial update from MD Anderson describes ongoing recruitment for a study assessing functional and symptom outcomes in survivors of…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study [Phase 2]
This document reports a Phase 2 clinical trial called HEADLIGHT evaluating intensity-modulated proton therapy or conventional X-ray therapy …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer [Phase 2]
An update on a Phase 2 trial evaluating a docetaxel/cisplatin/fluorouracil regimen for previously untreated Stage II-IV nasal cavity and par…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Toripalimab With Chemotherapy for Sinus Cancer [Phase 2]
A Phase 2 clinical trial evaluating toripalimab in combination with chemotherapy for sinonasal cancer and related paranasal sinus neoplasms …
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment [NA]
An update on a completed clinical trial evaluating exercise training and behavioral modification to boost physical activity in patients unde…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer [Phase 1]
Phase 1 study evaluating adding BAY 1895344 with radiation therapy to pembrolizumab for recurrent head and neck squamous cell carcinomas, ai…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages [Phase 2]
A Phase 2 trial evaluating endoscopic surgery followed by chemotherapy and proton radiation for paranasal sinus cancers and nasal cavity tum…
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses [Phase 2]
Phase 2 trial evaluating camrelizumab in combination with chemoradiotherapy for locoregional nasal cavity and paranasal sinus cancers.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Adaptive Radiotherapy for Head and Neck Cancer [Phase 2]
Phase 2 trial update on adaptive radiotherapy for head and neck cancers completed.
-
CLINICAL_TRIALS research · 2019-02-05Clinical Trial Update: Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer [NA]
Clinical trial update noting termination of a study evaluating olfactory training to improve sense of smell after radiation therapy in patie…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer [Phase 2]
Phase 2 clinical trial evaluating fluorouracil, hydroxyurea, cetuximab with twice-daily intensity-modulated radiation therapy for advanced h…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Photon/Proton Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses
A completed clinical trial evaluated photon/proton radiation therapy for cancers of the nasal cavity and paranasal sinuses.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 trial examining cisplatin with or without the WEE1 inhibitor MK-1775 in recurrent or metastatic head and neck cancers was terminated…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of erlotinib and celecoxib with reirradiation in recurrent head and neck cancer; results posted i…
-
CLINICAL_TRIALS research · 2016-08-30Clinical Trial Update: Application of Guidelines for Medico-professional Supervision of Workers Exposed to Carcinogenic Action of Wood Dust: CERBois Cohort
Completed CERBois cohort study examining the application of medico-professional guidelines for supervising workers exposed to carcinogenic w…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 study of dasatinib in patients with recurrent or metastatic head and neck cancer has completed and posted results.